Literature DB >> 3262458

Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

J Devière1, C Denys, L Schandene, F Romasco, M Adler, J Wybran, E Dupont.   

Abstract

Peripheral blood mononuclear cells from 15 patients with alcoholic cirrhosis (AC) and 15 matched healthy controls were tested for their proliferative response to mitogens such as PHA and con A, tumour promoter PMA and OKT3 monoclonal antibody, for their capacity to produce IL-2 and to respond to recombinant IL-2 (rIL-2). The expression of IL-2 receptor (Tac) together with two other activation markers, the receptor for transferrin (T9) and Ia antigen have also been assessed. A profound decrease of proliferative response was observed after stimulation by lectins and PMA. IL-2 production was significantly decreased (0.39 +/- 0.07 versus 0.82 +/- 0.009 units; P less than 0.001) in alcoholic cirrhosis. Resting PBMC of these patients disclosed spontaneous responsiveness to rIL-2 without requiring prestimulation with PHA as observed in healthy subjects. This abnormal response was associated with significantly increased percentages of Tac (19.4 +/- 3.1 versus 5.1 +/- 1.1%; P less than 0.001), T9 (13.6 +/- 3.3 versus 6.6 +/- 1.1%; P = 0.04) and Ia positive cells (21.4 +/- 5.4 versus 11.5 +/- 1.4; P less than 0.05) in alcoholic cirrhosis. Defective proliferative activity and impaired IL-2 production, combined with an increase of lymphocytes bearing T cell activation markers and of rIL-2 responsiveness could represent in vitro correlates for mechanisms leading to immunoregulatory disturbances in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262458      PMCID: PMC1541554     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  Mechanisms of abnormalities in host defences against bacterial infection in liver disease.

Authors:  I A Rajkovic; R Williams
Journal:  Clin Sci (Lond)       Date:  1985-03       Impact factor: 6.124

2.  T-cell subsets in peripheral blood and ascitic fluid of patients with alcoholic liver cirrhosis.

Authors:  S Pirrone; F Tosato; P Rossi; V Fossaluzza; E Tonutti; P G Sala
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

Review 3.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

4.  Transferrin receptor expression by stimulated cells in mixed lymphocyte culture.

Authors:  M Salmon; P A Bacon; D P Symmons; K W Walton
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

5.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

Review 6.  Infections in the alcoholic.

Authors:  H G Adams; C Jordan
Journal:  Med Clin North Am       Date:  1984-01       Impact factor: 5.456

7.  The degree of monocyte participation in human B- and T-cell activation by phorbol myristate acetate.

Authors:  I Sugawara; S Ishizaka
Journal:  Clin Immunol Immunopathol       Date:  1983-03

8.  Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease.

Authors:  G J Alexander; K T Nouri-Aria; A L Eddleston; R Williams
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

9.  Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.

Authors:  J F Schneider; A L Baker; N W Haines; G Hatfield; J L Boyer
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

10.  Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.

Authors:  H Kawanishi; H Tavassolie; R P MacDermott; J N Sheagren
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

View more
  5 in total

1.  Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease.

Authors:  R T Cook; M J Garvey; B M Booth; J A Goeken; B Stewart; M Noel
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

2.  High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

Authors:  J Deviere; J Content; C Denys; P Vandenbussche; L Schandene; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 3.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

4.  The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data.

Authors:  David U Lee; Gregory H Fan; David J Hastie; Vibhav N Prakasam; Elyse A Addonizio; Ryan R Ahern; Kristen J Seog; Raffi Karagozian
Journal:  J Clin Exp Hepatol       Date:  2021-02-04

Review 5.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.